abstract |
3,5-diaminopyrazole, for example, compounds of formula (I) and pharmaceutical compositions thereof useful for the modulation of kinase activity modulated in COPD are provided herein. Also provided herein are methods of using the same to treat, prevent, or alleviate one or more symptoms of an RC kinase-mediated disorder, disease, or disease. (I) |